- Home
- PLTK vs CVAC Comparison
PLTK vs CVAC Comparison
Compare PLTK & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- CVAC
- Stock Information
- Founded
- PLTK 2010
- CVAC 2000
- Country
- PLTK Israel
- CVAC Germany
- Employees
- PLTK N/A
- CVAC N/A
- Industry
- PLTK EDP Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- PLTK Technology
- CVAC Health Care
- Exchange
- PLTK Nasdaq
- CVAC Nasdaq
- Market Cap
- PLTK 1.4B
- CVAC 1.2B
- IPO Year
- PLTK 2021
- CVAC 2020
- Fundamental
- Price
- PLTK $3.69
- CVAC $5.34
- Analyst Decision
- PLTK Buy
- CVAC Hold
- Analyst Count
- PLTK 9
- CVAC 3
- Target Price
- PLTK $7.19
- CVAC $6.83
- AVG Volume (30 Days)
- PLTK 1.9M
- CVAC 450.0K
- Earning Date
- PLTK 11-06-2025
- CVAC 11-12-2025
- Dividend Yield
- PLTK 10.90%
- CVAC N/A
- EPS Growth
- PLTK N/A
- CVAC N/A
- EPS
- PLTK 0.23
- CVAC 1.01
- Revenue
- PLTK $2,673,100,000.00
- CVAC $599,540,810.00
- Revenue This Year
- PLTK $9.56
- CVAC N/A
- Revenue Next Year
- PLTK $2.86
- CVAC $23.40
- P/E Ratio
- PLTK $15.89
- CVAC $5.31
- Revenue Growth
- PLTK 4.98
- CVAC 675.15
- 52 Week Low
- PLTK $3.31
- CVAC $2.37
- 52 Week High
- PLTK $8.80
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- PLTK 51.47
- CVAC 40.70
- Support Level
- PLTK $3.62
- CVAC $5.33
- Resistance Level
- PLTK $3.84
- CVAC $5.41
- Average True Range (ATR)
- PLTK 0.12
- CVAC 0.04
- MACD
- PLTK 0.02
- CVAC -0.01
- Stochastic Oscillator
- PLTK 53.95
- CVAC 37.50
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.